Cantor Fitzgerald Reiterates Overweight on Humana, Maintains $597 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Humana (NYSE:HUM) and maintained a price target of $597.
September 14, 2023 | 3:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Humana, maintaining a price target of $597.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Humana. The maintained price target of $597 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100